Skip to main content
Premium Trial:

Request an Annual Quote

Northwestern University, Open Biosystems, CytRx


Northwestern Joins Open Biosystems Open Access Program

Open Biosystems said this week that Northwestern University has joined the company's Open Access RNAi Program.

As reported by RNAi News, the program is designed to make Open Biosystems' genome-wide shRNA libraries more affordable for the company's academic customer base (see RNAi News, 2/2/2006).

By joining the program, Open Biosystems said Northwestern's community of 270 participating research labs will gain access to the company's shRNA libraries. Financial terms of the arrangement were not disclosed.

CytRx Inks Deals to Sell $13.4M in Stock, Warrants

CytRx said last week that it has entered into definitive agreements with a group of institutional investors to sell roughly $13.4 million in common stock and warrants.

Under the terms of the financing, CytRx will sell 10.65 million shares of common stock at $1.26 per share and issue warrants to purchase approximately 5.33 million shares of common stock at an exercise price of $1.54 per share. CytRx said it will net about $12.4 million through the placement.

The signing of the agreements comes at a time when CytRx is struggling under a cash crunch and is seeking funds to spin out its RNAi therapeutics operations (see RNAi News, 2/2/2006 and 2/16/2006).

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.